http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1031748-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00 |
| filingDate | 1964-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1966-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1031748-A |
| titleOfInvention | 16-substituted androstanes |
| abstract | The invention comprises compounds of formula <FORM:1031748/C2/1> wherein R is oxygen or a -(H)-b -(OR1), and R1 is hydrogen or an acyl group having 2 to 5 carbon atoms, and their preparation by (a) catalytic hydrogenation of a corresponding androst-5-en-16-ylidene acetic acid, (b) partial or complete hydrolysis of a diacrylate, (c) acylation, or (d) oxidation of a 3-ol to a 3-ketone with chromium trioxide. The compounds of the invention have anabolic activity. 3b ,17b - Diacetoxy - 5a - androstan - 16b - yl acetic acid and 3b ,17b -dihydroxy-5(a or b ) androstan-16b -yl acetic acid lactone are obtained as by-products from the above mentioned hydrogenation process. |
| priorityDate | 1963-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.